Palvella Therapeutics, Inc. Unrealized Gain (Loss) on Investments
Palvella Therapeutics, Inc. (PVLA) reported Unrealized Gain (Loss) on Investments of -$30.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2026-08-04
- Palvella Therapeutics, Inc. unrealized gain (loss) on investments for the quarter ending 2026-06-30 was -$30.00K.
- Palvella Therapeutics, Inc. unrealized gain (loss) on investments for the quarter ending 2026-03-31 was $4.00K.
- Palvella Therapeutics, Inc. unrealized gain (loss) on investments for the quarter ending 2025-06-30 was $0.00.
- Palvella Therapeutics, Inc. unrealized gain (loss) on investments for the quarter ending 2025-03-31 was $0.00.
- Palvella Therapeutics, Inc. unrealized gain (loss) on investments for fiscal 2023 was $74.00K.
- Palvella Therapeutics, Inc. unrealized gain (loss) on investments for fiscal 2022 was -$73.00K.
- Palvella Therapeutics, Inc. unrealized gain (loss) on investments for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Palvella Therapeutics, Inc. unrealized gain (loss) on investments for fiscal 2020 was $70.00K.
| Period end | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 6 month | Unrealized Gain (Loss) on Investments 9 month | Unrealized Gain (Loss) on Investments 12 month | Unrealized Gain (Loss) on Investments 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$30.00K 10-Q · filed 2026-08-04 | -$26.00K 10-Q · filed 2026-08-04 | |||
| 2026-03-31 | $4.00K 10-Q · filed 2026-08-04 | ||||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-04 | $0.00 10-Q · filed 2026-08-04 | |||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-07 | ||||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $0.00 derived: sum of 2 quarters · filed 2024-11-13 | -$1.00K 10-Q · filed 2024-11-13 | -$1.00K derived: sum of 4 quarters · filed 2024-11-13 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$1.00K 10-Q · filed 2024-08-14 | -$1.00K derived: sum of 3 quarters · filed 2024-08-14 | $1.00K derived: sum of 4 quarters · filed 2024-11-13 | |
| 2024-03-31 | -$1.00K 10-Q · filed 2024-05-15 | -$1.00K derived: sum of 2 quarters · filed 2024-05-15 | $1.00K derived: sum of 3 quarters · filed 2024-11-13 | $3.00K derived: sum of 4 quarters · filed 2024-11-13 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $2.00K derived: sum of 2 quarters · filed 2024-11-13 | $4.00K derived: sum of 3 quarters · filed 2024-11-13 | $74.00K 10-K · filed 2024-03-29 | |
| 2023-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $4.00K derived: sum of 2 quarters · filed 2024-11-13 | $74.00K 10-Q · filed 2024-11-13 | -$81.00K derived: sum of 4 quarters · filed 2024-11-13 | |
| 2023-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $72.00K 10-Q · filed 2024-08-14 | -$83.00K derived: sum of 3 quarters · filed 2024-08-14 | -$153.00K derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | $70.00K 10-Q · filed 2024-05-15 | -$85.00K derived: sum of 2 quarters · filed 2024-05-15 | -$155.00K derived: sum of 3 quarters · filed 2024-05-15 | $16.00K derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | -$155.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$225.00K derived: sum of 2 quarters · filed 2024-03-29 | -$54.00K derived: sum of 3 quarters · filed 2024-03-29 | -$73.00K 10-K · filed 2024-03-29 | |
| 2022-09-30 | -$70.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $101.00K derived: sum of 2 quarters · filed 2023-11-14 | $82.00K 10-Q · filed 2023-11-14 | $82.00K derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $171.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $152.00K 10-Q · filed 2023-08-10 | $152.00K derived: sum of 3 quarters · filed 2023-08-10 | $152.00K derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-03-31 | -$19.00K 10-Q · filed 2023-05-11 | -$19.00K derived: sum of 2 quarters · filed 2023-05-11 | -$19.00K derived: sum of 3 quarters · filed 2023-05-11 | -$19.00K derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $0.00 derived: sum of 3 quarters · filed 2023-03-31 | $0.00 10-K · filed 2023-03-31 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $0.00 derived: sum of 2 quarters · filed 2022-11-04 | $0.00 10-Q · filed 2022-11-04 | $389.00K derived: sum of 4 quarters · filed 2022-11-04 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $0.00 10-Q · filed 2022-08-04 | $389.00K derived: sum of 3 quarters · filed 2022-08-04 | $39.00K derived: sum of 4 quarters · filed 2022-08-04 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-11 | $389.00K derived: sum of 2 quarters · filed 2022-05-11 | $39.00K derived: sum of 3 quarters · filed 2022-05-11 | $24.00K derived: sum of 4 quarters · filed 2022-05-11 | |
| 2020-12-31 | $389.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $39.00K derived: sum of 2 quarters · filed 2021-11-02 | $24.00K derived: sum of 3 quarters · filed 2021-11-02 | $70.00K 10-K · filed 2021-03-31 | |
| 2020-09-30 | -$350.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | -$365.00K derived: sum of 2 quarters · filed 2021-11-02 | -$319.00K 10-Q · filed 2021-11-02 | -$788.00K derived: sum of 4 quarters · filed 2021-11-02 | |
| 2020-06-30 | -$15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $31.00K 10-Q · filed 2021-08-05 | -$438.00K derived: sum of 3 quarters · filed 2021-08-05 | -$62.00K derived: sum of 4 quarters · filed 2021-08-05 | |
| 2020-03-31 | $46.00K 10-Q · filed 2021-05-17 | -$423.00K derived: sum of 2 quarters · filed 2021-05-17 | -$47.00K derived: sum of 3 quarters · filed 2021-05-17 | -$284.00K derived: sum of 4 quarters · filed 2021-05-17 | |
| 2019-12-31 | -$469.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -$93.00K derived: sum of 2 quarters · filed 2021-03-31 | -$330.00K derived: sum of 3 quarters · filed 2021-03-31 | $0.00 10-K · filed 2021-03-31 | $14.00K 10-K · filed 2020-03-13 |
| 2019-09-30 | $376.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $139.00K derived: sum of 2 quarters · filed 2020-11-04 | $469.00K 10-Q · filed 2020-11-04 | $54.00K derived: sum of 4 quarters · filed 2020-11-04 | |
| 2019-06-30 | -$237.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $93.00K 10-Q · filed 2020-08-10 | -$322.00K derived: sum of 3 quarters · filed 2020-08-10 | -$893.00K derived: sum of 4 quarters · filed 2020-08-10 | |
| 2019-03-31 | $330.00K 10-Q · filed 2020-05-11 | -$85.00K derived: sum of 2 quarters · filed 2020-05-11 | -$656.00K derived: sum of 3 quarters · filed 2020-05-11 | $1.71M derived: sum of 4 quarters · filed 2020-05-11 | |
| 2018-12-31 | -$415.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | -$986.00K derived: sum of 2 quarters · filed 2020-03-13 | $1.38M derived: sum of 3 quarters · filed 2020-03-13 | $681.00K 10-K · filed 2020-03-13 | |
| 2018-09-30 | -$571.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $1.79M derived: sum of 2 quarters · filed 2019-11-12 | $1.10M 10-Q · filed 2019-11-12 | $276.00K derived: sum of 4 quarters · filed 2019-11-12 | |
| 2018-06-30 | $2.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $1.67M 10-Q · filed 2019-08-09 | $847.00K derived: sum of 3 quarters · filed 2019-08-09 | $847.00K derived: sum of 4 quarters · filed 2019-08-09 | |
| 2018-03-31 | -$697.00K 10-Q · filed 2019-05-10 | -$1.52M derived: sum of 2 quarters · filed 2019-05-10 | -$1.52M derived: sum of 3 quarters · filed 2019-05-10 | -$1.52M derived: sum of 4 quarters · filed 2019-05-10 | |
| 2017-12-31 | -$820.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | -$820.00K derived: sum of 2 quarters · filed 2019-03-18 | -$820.00K derived: sum of 3 quarters · filed 2019-03-18 | -$820.00K 10-K · filed 2019-03-18 | $820.00K 10-K · filed 2018-03-15 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $0.00 derived: sum of 2 quarters · filed 2018-11-07 | $0.00 10-Q · filed 2018-11-07 | ||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $0.00 10-Q · filed 2018-08-09 | |||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-10 | ||||
| 2016-12-31 | $0.00 10-K · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |